Zacks Investment Research Lowers Addus Homecare (NASDAQ:ADUS) to Hold

Zacks Investment Research downgraded shares of Addus Homecare (NASDAQ:ADUS) from a strong-buy rating to a hold rating in a report issued on Tuesday morning, Zacks.com reports.

According to Zacks, “ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company’s services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing. “

A number of other brokerages also recently issued reports on ADUS. Sidoti increased their price target on shares of Addus Homecare from $84.00 to $96.00 and gave the company a buy rating in a report on Tuesday, August 6th. BMO Capital Markets set a $85.00 target price on shares of Addus Homecare and gave the company a hold rating in a report on Wednesday, August 7th. Raymond James set a $92.00 target price on shares of Addus Homecare and gave the company an outperform rating in a report on Wednesday, August 7th. BidaskClub upgraded shares of Addus Homecare from a hold rating to a buy rating in a report on Saturday, July 27th. Finally, Oppenheimer raised their target price on shares of Addus Homecare from $80.00 to $91.00 and gave the company a buy rating in a report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of Buy and a consensus price target of $83.44.

Shares of ADUS opened at $86.70 on Tuesday. The company has a 50-day simple moving average of $78.79 and a 200-day simple moving average of $70.13. The company has a quick ratio of 2.87, a current ratio of 2.84 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $1.11 billion, a PE ratio of 46.51, a P/E/G ratio of 2.56 and a beta of -0.10. Addus Homecare has a 52-week low of $56.75 and a 52-week high of $87.78.

Addus Homecare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, August 5th. The company reported $0.47 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.47. The business had revenue of $149.69 million during the quarter, compared to the consensus estimate of $146.66 million. Addus Homecare had a net margin of 3.31% and a return on equity of 8.55%. On average, research analysts anticipate that Addus Homecare will post 2.01 EPS for the current year.

In related news, insider W Bradley Bickham sold 15,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $80.67, for a total value of $1,210,050.00. Following the sale, the insider now directly owns 38,311 shares of the company’s stock, valued at $3,090,548.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Mark L. First sold 440,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $74.08, for a total transaction of $32,595,200.00. Following the completion of the sale, the director now directly owns 19,151 shares in the company, valued at $1,418,706.08. The disclosure for this sale can be found here. Insiders own 20.10% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. C M Bidwell & Associates Ltd. acquired a new stake in shares of Addus Homecare in the second quarter worth approximately $40,000. Marshall Wace North America L.P. acquired a new stake in shares of Addus Homecare in the first quarter worth approximately $34,000. Bank of Montreal Can boosted its position in shares of Addus Homecare by 58.9% in the first quarter. Bank of Montreal Can now owns 545 shares of the company’s stock worth $35,000 after acquiring an additional 202 shares during the last quarter. Exane Derivatives acquired a new stake in shares of Addus Homecare in the second quarter worth approximately $95,000. Finally, South Dakota Investment Council acquired a new stake in shares of Addus Homecare in the first quarter worth approximately $83,000. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Addus Homecare Company Profile

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.

Further Reading: Holder of Record

Get a free copy of the Zacks research report on Addus Homecare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Addus Homecare (NASDAQ:ADUS)

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.